News | Artificial Intelligence | October 26, 2022

Industry life sciences veteran to advance growth strategy and execution

Jieun Choe, chief marketing officer, Viz.ai. Source: Viz.ai

Jieun Choe, chief marketing officer, Viz.ai. Source: Viz.ai 

 


October 26, 2022 —  Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, has named life sciences veteran Jieun Choe as chief marketing officer (CMO). Choe will report to CEO Chris Mansi, overseeing global marketing strategy, brand and communications, product marketing and demand generation. 

“Jieun’s deep experience and proven track record in driving growth with expert execution will be invaluable as we continue to expand our footprint worldwide,” said CEO Chris Mansi, M.D. “The addition of her customer-centric approach and strategic, growth mindset to our c-suite will help propel Viz.ai into new frontiers.” 

Choe was most recently chief strategy and marketing officer at Certara, a global leader in biosimulation, where she headed the global marketing team and drove the strategic planning process. Choe was also instrumental in helping lead the company to a successful IPO in December 2020. Earlier in her career, she worked in product management and strategy at Guidant and Boston Scientific, leading cross-functional teams and driving product strategy and launches. 

“I am thrilled to join Viz.ai as it embarks on its next stage of growth,” said Choe. “The company’s purpose-driven, diverse culture is impressive, empowering the Viz team to innovate outstanding solutions to improve patient outcomes and increase access to life-saving care. I look forward to working with the team to accelerate the momentum and fuel growth.” 

Choe received her Bachelors of Arts in Public Policy and Economics from Stanford University and a Masters of Business Administration from Stanford University’s Graduate School of Business

For more information: www.viz.ai 

Find more RSNA22 coverage here


Related Content

News | Radiation Oncology

July 10, 2026 — A new study led by researchers at the Icahn School of Medicine at Mount Sinai found that although the ...

Time July 10, 2026
arrow
News | Ultrasound Imaging

July 7, 2026 — Longeviti Neuro Solutions has launched a new strategic initiative, ClearFit AI, a Brain Ultrasound ...

Time July 09, 2026
arrow
News | Prostate Cancer

July 8,2026 — CorePlus, Puerto Rico’s fully digital precision pathology and clinical laboratory, has announced the ...

Time July 08, 2026
arrow
News | Women's Health

July 1, 2026 — Despite declining birth rates worldwide, the complexity of pregnancy is increasing. Advanced maternal age ...

Time July 01, 2026
arrow
News | Information Technology

June 26, 2026 — Radin Health recently announced the successful deployment of its cloud-native platform at four ...

Time June 26, 2026
arrow
News | FDA

June 25, 2026 — Aidoc recently announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device ...

Time June 25, 2026
arrow
News | Interventional Radiology

June 25, 2026 — Radiologists performing no interventional radiology-related (IR-related) work increased from one-third ...

Time June 25, 2026
arrow
News | Mammography

June 23, 2026 — Using artificial intelligence (AI), researchers found that image-based risk scores for breast cancer ...

Time June 24, 2026
arrow
News | Pediatric Imaging

June 16, 2026 — Crescom has officially launched a global clinical Proof of Concept (PoC) of its pediatric ...

Time June 24, 2026
arrow
News | Information Technology

June 24, 2026 — HOPPR Presto Agent (Presto) is now commercially available from HOPPR. Presto iis a tool that ntegrates ...

Time June 24, 2026
arrow
Subscribe Now